Project Grant HT94252510475
Award Date
9/30/25
Completion Date
9/29/28
Dollars Obligated
$1.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
The Department of Defense's Defense Health Agency awarded a $232,878 Project Grant to The Johns Hopkins University to conduct research on "EXPLORING THE ROLE OF EPITRANSCRIPTOMICS IN THE EVOLUTION OF NEUROENDOCRINE PROSTATE CANCER." This grant is funded through the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The research will be conducted from...
The Department of Defense's Defense Health Agency awarded a $465,750 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Johns Hopkins University. The grant, titled "ESTROGEN RECEPTOR MUTATIONS AS A NOVEL BIOMARKER FOR RESPONSE TO ENDOCRINE THERAPY IN OVARIAN CANCER," will fund research to investigate estrogen receptor mutations as a potential biomarker for improved response to endocrine therapy in ovarian cancer patients. The grant period...
The U.S. Defense Health Agency awarded a $1,552,513 Project Grant to The Johns Hopkins University under the Military Medical Research and Development (CFDA 12.420) program. The grant supports noninvasive machine learning analyses of cell-free DNA fragmentomes for the early detection of liver cancer. The research will be conducted at The Johns Hopkins University's facilities in Baltimore, Maryland over a project period from July 1, 2025 to June 30, 2028. This grant award reflects the Defense...
The Department of Defense's Defense Health Agency awarded a $318,483 Project Grant to The Johns Hopkins University under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the funding will be used for a 2-year project to quantitatively measure acute and chronic lesion activity in a real-world, multi-site clinical MRI...
The Department of Defense's Defense Health Agency awarded a $1,553,332 Project Grant to The Johns Hopkins University to support research on the "IMPACT OF BREAST TISSUE MICROBIOTA ON BREAST CANCER PROGRESSION" under the Military Medical Research and Development (CFDA 12.420) program. The 3-year grant, effective from October 1, 2025 to September 30, 2028, will fund advanced biomedical research to transform healthcare for military service members, veterans, and the public. The research...
The Johns Hopkins University received a three-year, $651,158 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support the university's research into early assessment of treatment response in breast cancer patients undergoing neoadjuvant therapy using an automated liquid biopsy-breast cancer methylation assay. The Military Medical Research and Development program aims to transform military...
This federal Project Grant award of $1,228,021.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is supporting The Johns Hopkins University in advancing clinical research in ovarian cancer. The grant, awarded on June 1, 2024, will fund the university's efforts to conduct innovative scientific studies and clinical trials over a four-year performance period ending on May 31, 2028. This award enables Johns Hopkins to leverage its expertise...
The Department of Defense's Defense Health Agency awarded a $319,240 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Johns Hopkins University. The grant, awarded on September 1, 2025, will fund research to characterize microRNAs involved in regulating human oligodendrocyte maturation and myelin formation. This research, to be conducted over 2 years until August 31, 2027, aims to transform healthcare for military service members, veterans, and the...
The U.S. Defense Health Agency has awarded a $655,000 Project Grant to The Johns Hopkins University under the Military Medical Research and Development (CFDA 12.420) program. The grant, which runs from September 1, 2024 to August 31, 2028, supports research to identify and circumvent resistance after donor-derived ex vivo expanded natural killer (NK) cells and haploidentical hematopoietic cell transplantation (haplo-HCT) in children and young adults with high-risk acute myeloid leukemia (AML)....
The U.S. Defense Health Agency awarded a $621,011 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Johns Hopkins University. The grant, with a performance period from July 1, 2025 to June 30, 2027, will fund research targeting sensory neurons via anti-CGRP therapies in osteosarcoma. As a leading federal contractor and grantee, The Johns Hopkins University has demonstrated extensive capabilities in advanced biomedical research across diverse medical...